Gastric HER2 testing study (GaTHER): Evaluation of gastric cancer testing accuracy in Australia

被引：1
|
作者：
Kumarasinghe, M. P.
Morey, A.
Bilous, M.
Fox, S. B.
机构：
[1] Queen Elizabeth II Med Ctr, PathWest, Perth, WA, Australia
[2] St Vincents Hosp, SydPath, Sydney, NSW 2010, Australia
[3] Westmead Hosp, Sydney, NSW, Australia
[4] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 04期
关键词：
D O I：
10.1200/jco.2011.29.4_suppl.15
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Epidemiologic study on HER2 (+) early/advanced stage gastric cancer: An evaluation on HER2 positivity in gastric and gastroesophageal junction cancers
    Erdamar, S.
    Kepil, N.
    Dursun, A.
    Ekinci, O.
    Sagol, O.
    Sarioglu, S.
    Doganavsargil, B.
    Sezak, M.
    Ozdener, F.
    Ustundag, K.
    VIRCHOWS ARCHIV, 2014, 465 : S148 - S148
  • [32] HER2 Testing in Malignant Effusions of Metastatic Gastric Carcinoma: Is it Feasible?
    Wong, Daniel D.
    de Boer, W. Bastiaan
    Platten, Michael A.
    Jo, Vickie Y.
    Cibas, Edmund S.
    Kumarasinghe, M. Priyanthi
    DIAGNOSTIC CYTOPATHOLOGY, 2015, 43 (01) : 80 - 85
  • [33] HER2 Testing in Gastric and Gastroesophageal Adenocarcinoma-Review and Update
    Koro, Konstantin
    Swanson, Paul E.
    Yeh, Matthew M.
    AJSP-REVIEWS AND REPORTS, 2019, 24 (04) : 179 - 187
  • [34] A survival guide to HER2 testing in gastric/gastroesophageal junction carcinoma
    Subasinghe, Duminda
    Acott, Nathan
    Kumarasinghe, Marian Priyanthi
    Path, Dip
    GASTROINTESTINAL ENDOSCOPY, 2019, 90 (01) : 44 - 54
  • [35] What are NCI-designated cancer centers using for gastric and esophageal cancer HER2 testing?
    Trosman, Julia R.
    Weldon, Christine B.
    Tsongalis, Gregory J.
    Schink, Julian C.
    Benson, Al Bowen
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing
    Rueschoff, Josef
    Dietel, Manfred
    Baretton, Gustavo
    Arbogast, Susanne
    Walch, Axel
    Monges, Genevieve
    Chenard, Marie-Pierre
    Penault-Llorca, Frederique
    Nagelmeier, Iris
    Schlake, Werner
    Hoefler, H.
    Kreipe, H. H.
    VIRCHOWS ARCHIV, 2010, 457 (03) : 299 - 307
  • [37] HER2 in focus—gastric cancer
    Aysegül Ilhan-Mutlu
    memo - Magazine of European Medical Oncology, 2023, 16 : 217 - 217
  • [38] SERUM HER2 IN GASTRIC CANCER
    Saito, M.
    Kaneto, H.
    Okuda, H.
    Kodaira, J.
    Hagiwara, T.
    Kozawa, H.
    Yoshimoto, M.
    Yamashita, K.
    Arimura, Y.
    Shinomura, Y.
    ANNALS OF ONCOLOGY, 2013, 24 : 33 - 33
  • [39] HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer
    Gomez-Martin, Carlos
    Garralda, Elena
    Jose Echarri, M.
    Ballesteros, Anabel
    Arcediano, Alberto
    Luis Rodriguez-Peralto, Jose
    Hidalgo, Manuel
    Lopez-Rios, Fernando
    JOURNAL OF CLINICAL PATHOLOGY, 2012, 65 (08) : 751 - 757
  • [40] HER2 AND OTHER BIOMARKER TESTING PATTERNS AMONG PATIENTS WITH ADVANCED GASTRIC CANCER (GC) OR GASTRIC ESOPHAGEAL JUNCTION CANCER (GEJC)
    Mehta, S.
    Herms, L.
    Chou, L. N.
    Lam, C. K.
    Kwong, W. J.
    Cosgrove, D.
    VALUE IN HEALTH, 2022, 25 (07) : S497 - S497
12345